Sergey Alexeev

Dr. Sergey Alexeev is a Senior Research Fellow in Health Economics at the University of Sydney's Faculty of Medicine and Health (FMH), affiliated with the NHMRC Clinical Trials Centre. His research focuses on quasi-experimental and clinical trial methodologies, with applications in drug policy, public health, and criminology. He holds degrees from the University of Paris Dauphine, Trinity College Dublin, York University, and the University of Technology Sydney, supported by prestigious scholarships totaling AUD 150,000. His work bridges health economics, criminology, and policy analysis.

**Research Interests**: Health economics, addiction policy, crime prevention, and methodological innovation in clinical trials. He leads projects like the HOPE initiative evaluating post-incarceration outcomes and the ENCORE trial transforming nursing practices in acute hospitals. His studies often integrate quasi-experimental designs with randomized trials, emphasizing causal inference.

**Articles and Impact**: Recent work includes evaluating drug policing effectiveness (Journal of Law and Economics), naloxone policy (Economic Inquiry), and supervised injection sites' economic impacts (Regional Science and Urban Economics). These studies have shaped public policy, such as NSW’s fine reforms and Australia’s drug law debates, with extensive media coverage in outlets like The Sydney Morning Herald and Forbes.

• Scientific Awards: Multiple scholarships, including the Ross Milbourne Research Scholarship, and AUD 500,000 in grants for incarceration policy analysis.
• Advising and Grants: Mentors HDR student Alex Gallagher and leads teams advancing Bayesian adaptive trials. Secured funding from NSW Department of Community and Justice.
• Labs/Teams: NHMRC Clinical Trials Centre and collaborations with Lancaster University on addiction and economic mobility.